These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27928358)

  • 21. Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome.
    Eyre M; Hameed A; Wright S; Brownlee W; Ciccarelli O; Bowman R; Lim M; Wassmer E; Thompson D; Hemingway C; Hacohen Y
    Dev Med Child Neurol; 2018 Dec; 60(12):1244-1250. PubMed ID: 29637998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
    Tanaka M; Tanaka K
    J Neuroimmunol; 2014 May; 270(1-2):98-9. PubMed ID: 24703097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
    Narayan RN; McCreary M; Conger D; Wang C; Greenberg BM
    Mult Scler Relat Disord; 2019 Feb; 28():86-90. PubMed ID: 30576847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients.
    Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O
    Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
    Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
    Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis.
    Liu H; Zhou H; Wang J; Sun M; Teng D; Song H; Xu Q; Wei S
    J Neurol Sci; 2019 Jan; 396():225-231. PubMed ID: 30522039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection.
    Sun CB
    Front Immunol; 2023; 14():1296518. PubMed ID: 38054007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic implications of MOG/AQP4 antibodies in recurrent optic neuritis.
    Peng Y; Liu L; Zheng Y; Qiao Z; Feng K; Wang J
    Exp Ther Med; 2018 Aug; 16(2):950-958. PubMed ID: 30112048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies.
    Zhou L; Tan X; Wang L; Zhao X; Qiu W; Yang H
    J Ophthalmol; 2022; 2022():4951491. PubMed ID: 35360549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Paediatric Patients with Optic Neuritis].
    Tegetmeyer H; Merkenschlager A
    Klin Monbl Augenheilkd; 2017 Oct; 234(10):1243-1249. PubMed ID: 29025172
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome.
    Etemadifar M; Abbasi M; Salari M; Etemadifar F; Tavakoli H
    Mult Scler Relat Disord; 2019 Jan; 27():127-130. PubMed ID: 30368225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.
    Jelcic I; Hanson JVM; Lukas S; Weber KP; Landau K; Pless M; Reindl M; Weller M; Martin R; Lutterotti A; Schippling S
    J Neuroophthalmol; 2019 Mar; 39(1):3-7. PubMed ID: 30015656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China.
    Song H; Zhou H; Yang M; Wang J; Liu H; Sun M; Xu Q; Wei S
    J Ophthalmol; 2019; 2019():4015075. PubMed ID: 31061727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-MOG antibody in different types of immune-mediated optic neuritis].
    Kong XY; Peng JT; Liu LJ; Yan R; Zhang XJ
    Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1069-72. PubMed ID: 23336409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and prognosis of optic neuritis in Taiwan - a hospital-based cohort study.
    Lin CW; Chen WT; Lin YH; Hung K; Chen TC
    Mult Scler Relat Disord; 2023 Jul; 75():104739. PubMed ID: 37148579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
    Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N
    Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody.
    Takano S; Hanabusa A; Yoshikawa Y; Sassa K; Shimura A; Shoji T; Ohde H; Shinoda K; Yamanouchi H
    Front Neurol; 2019; 10():1339. PubMed ID: 31920953
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
    Kim SM; Woodhall MR; Kim JS; Kim SJ; Park KS; Vincent A; Lee KW; Waters P
    Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e163. PubMed ID: 26516628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients.
    Giacomini T; Foiadelli T; Annovazzi P; Nosadini M; Gastaldi M; Franciotta D; Panarese C; Capris P; Camicione P; Lanteri P; De Grandis E; Prato G; Cordani R; Nobili L; Morana G; Rossi A; Pistorio A; Cellerino M; Uccelli A; Sartori S; Savasta S; Mancardi MM
    Mult Scler Relat Disord; 2020 Apr; 39():101917. PubMed ID: 31896061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.